Menu
Menu
We’re excited to celebrate Genos Médica, a leader in genetic and genomic medicine in Mexico, as they expand their collaboration with SOPHiA GENETICS to further their research using the SOPHiA DDM™ Platform.
Genos Médica is adopting SOPHiA DDM™ Exhanced Whole Exome and Liquid Biopsy applications to strengthen its research capabilities in rare disease and oncology, empowering its teams to uncover new insights that support the growth of precision medicine across Mexico and Latin America.
“Our collaboration withSOPHiA GENETICS allows us to explore the full potential of genomic data through cutting-edge applications like whole exome and liquid biopsy. These technologies will help advance our research efforts and expand the understanding of genetic variation in diverse populations.” said Dr. Melania Abreu González, Medical Geneticist, Genos Médica
At SOPHiA GENETICS, we’re proud to partner with research and clinical institutions worldwide that share our vision: democratizing data-driven medicine and accelerating discovery for a healthier future.
🔗 Learn more about our enhanced exome solutions here: https://sophiastg.wpenginepowered.com/sophia-ddm-for-genomics/inherited-disorders/sophia-ddm-enhanced-exome-solutions
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
